...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Good News for Zenith

Yes, very good news for Zenith this morning!

Zenith Epigenetics Announces Clinical Advancement of ZEN-3694

https://www.zenithepigenetics.com/newsroom/news-releases?article=34

 

Share
New Message
Please login to post a reply